Utility of Native T1 mapping to differentiate between athlete's heart and non-ischemic dilated cardiomyopathy by unknown
POSTER PRESENTATION Open Access
Utility of Native T1 mapping to differentiate
between athlete’s heart and non-ischemic dilated
cardiomyopathy
Ify Mordi1*, David Carrick1, Hiram Bezerra2, Nikolaos Tzemos1
From 18th Annual SCMR Scientific Sessions
Nice, France. 4-7 February 2015
Background
CMR has become an increasingly valuable tool in the
diagnosis and risk stratification of patients with non-
ischaemic dilated cardiomyopathy (DCM) due to its
assessment of left ventricular systolic function and tissue
characterization ability and may have a role in early
identification of cardiomyopathy. Some of the changes
associated with early DCM (left ventricular dilatation
and mild reduction in LV ejection fraction) can also
occur in patients with a history of significant aerobic
exercise, known as “athlete’s heart”. Using standard
echocardiographic and CMR parameters it may be diffi-
cult to differentiate between DCM and normal
physiological athletic adaptation, which may have signifi-
cant implications for the patient. We hypothesized that
use of CMR tagging and T1 and T2 mapping might be
useful to differentiate between patients with left ventri-
cular dilatation due to DCM and athlete’s heart.
Methods
105 male patients (27 healthy controls, 41 patients with
severe DCM - LVEF <35%, 16 sedentary patients and 21
athletes (both with LVEF 45-55%) underwent a compre-
hensive CMR protocol including tagging, T1 and T2
mapping and calculation of extracellular volume (ECV)
using a 1.5T scanner.
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Figure 1 Examples of the protocol for a healthy control (top) and patient with severe DCM (bottom). Top: A 52 year-old healthy male
control with a normal sized left ventricle (end-diastolic diameter 5.6 cm) and preserved left ventricular ejection fraction (57.8%) (A). Septal T2
was 51.6 ms (B), septal native T1 924.9 ms (C) and there was no LGE (D) or significant diffuse fibrosis (post-contrast T1 467.1 ms, ECV 27%, E).
GCS was -15.68% (F). Bottom: A 58 year-old severe DCM patient with a dilated left ventricle (end-diastolic diameter 8.0 cm) and severely
impaired left ventricular ejection fraction (28.4%) (G). Septal T2 was 59.8 ms (H), septal native T1 1017.8 ms (I). There was midwall LGE (J; arrow)
also reflected by the reduced post-contrast T1 and ECV (post-contrast T1 429.8 ms, ECV 35%, I; arrow). GCS was -5.15% (K).
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Results
GCS was significantly decreased in both athletes and
sedentary patients with compared to controls (GCS
-12.87 ± 3.61% vs. -13.05 ± 4.37% vs. -16.53 ± 2.01%,
p<0.001 respectively) while there was a trend to lower
GLS in athletes compared to controls. Native T1 and
ECV were significantly increased in sedentary mild DCM
patients compared to both healthy controls (native T1
1017 ± 42ms vs. 952 ± 31ms, p<0.001; ECV 31.2 ± 4.1%
vs. 26.2 ± 2.8%, p=0.003) and athletes (native T1 1017 ±
42ms vs. 958 ± 30ms, p<0.001; ECV 31.2 ± 4.1% vs. 26.4
± 6.8%, p=0.004). Using multivariable logistic regression
native T1 was the only significant parameter to differenti-
ate between athletes and sedentary patients with early
DCM (AUC 0.91).
Conclusions
T1 mapping is potentially a useful tool for differentiat-
ing between athlete’s heart and patients with early
DCM. T1 mapping could be used whenever differentia-
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Figure 2 Comparison between controls, patients with severe DCM, sedentary patients with mild DCM and athletes. Comparison
between the four groups using native T1 (A), ECV (B), GCS (C) and GLS (D).
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